Akoya BioSciences
AKYA
AKYA was delisted on the 7th of July, 2025.
58 hedge funds and large institutions have $16.3M invested in Akoya BioSciences in 2025 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 10 increasing their positions, 18 reducing their positions, and 26 closing their positions.
0.14% less ownership
Funds ownership: 25.24% → 25.1% (-0.14%)
9% less funds holding
Funds holding: 64 → 58 (-6)
23% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 26
44% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 18
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
50% less capital invested
Capital invested by funds: $32.8M → $16.3M (-$16.5M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $25K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OBAM
ODDO BHF Asset Management
Paris,
France
|
+$2.28M |
| 2 |
TC
Trium Capital
London,
United Kingdom
|
+$728K |
| 3 |
ECM
ExodusPoint Capital Management
New York
|
+$247K |
| 4 |
Jane Street
New York
|
+$198K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$173K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
N
Nuveen
Charlotte,
North Carolina
|
-$15.9M |
| 2 |
BlackRock
New York
|
-$1.34M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$387K |
| 4 |
State Street
Boston,
Massachusetts
|
-$381K |
| 5 |
JP Morgan Chase
New York
|
-$327K |
AKYA Hedge Fund Activity: Q2 2025 in Review
58 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Akoya BioSciences (AKYA) for Q2 2025, worth a combined $16.3M — down 50% from $32.8M a quarter earlier.
Sellers outnumbered buyers: 26 funds closed out of AKYA and 20 opened new positions — a net loss of 6 holders — while 18 trimmed existing stakes and 10 added.
The largest buyer was ODDO BHF Asset Management, opening a new position worth an estimated $2.28M. The largest seller was Nuveen, exiting entirely with an estimated $15.9M sold.
- 58 institutional investors held Akoya BioSciences (AKYA) as of Q2 2025, down from 64 in Q1 2025.
- Funds reported $16.3M of Akoya BioSciences stock for Q2 2025, down 50% quarter-over-quarter.
- 20 funds opened new Akoya BioSciences positions in Q2 2025 and 26 closed out, a net change of -6 holders.
- The largest Akoya BioSciences buyer in Q2 2025 was ODDO BHF Asset Management, an estimated $2.28M added.
- The largest Akoya BioSciences seller in Q2 2025 was Nuveen, an estimated $15.9M sold.
Based on aggregated 13F filings for Q2 2025.